| CTRI Number |
CTRI/2025/07/089910 [Registered on: 01/07/2025] Trial Registered Prospectively |
| Last Modified On: |
16/06/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparative evaluation of amniotic membrane with and without bioceramic material as pulpotomy agents |
|
Scientific Title of Study
|
Quantification of active MMP9 and comparative evaluation of Biodentine with and without Human Amniotic Membrane as pulpotomy agents in mature permanent molars with symptomatic irreversible pulpitis A randomized controlled trial. |
| Trial Acronym |
None |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Twyla Ferrao |
| Designation |
Postgraduate student |
| Affiliation |
Goa Dental College and Hospital |
| Address |
Department of Conservative Dentistry and Endodontics
Goa Dental College and Hospital, Bambolim, Goa 403202
India
North Goa GOA 403202 India |
| Phone |
8806240223 |
| Fax |
|
| Email |
tmcf095@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Marina Fernandes |
| Designation |
Professor |
| Affiliation |
Goa Dental College and Hospital |
| Address |
Department of Conservative Dentistry and Endodontics
Goa Dental College and Hospital, Bambolim, Goa 403202
India
North Goa GOA 403202 India |
| Phone |
9049666453 |
| Fax |
|
| Email |
docrmarina@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Marina Fernandes |
| Designation |
Professor |
| Affiliation |
Goa Dental College and Hospital |
| Address |
Department of Conservative Dentistry and Endodontics
Goa Dental College and Hospital, Bambolim, Goa 403202
India
North Goa GOA 403202 India |
| Phone |
9049666453 |
| Fax |
|
| Email |
docrmarina@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dr Twyla Ferrao |
| Address |
Department of Conservative Dentistry and Endodontics
Goa Dental College and Hospital
Bambolim Goa 403202
India |
| Type of Sponsor |
Other [Self funded ] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Twyla Ferrao |
Goa Dental College and Hospital |
Goa Dental College and Hospital
Bambolim Goa
403202
India North Goa GOA |
8806240223
tmcf095@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Goa Dental College and Hospital Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Pulpitis |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Biodentine |
Coronal Pulpotomy in mandibular molars using Biodentine as pulpotomy agents. Restoration with RMGIC and composite restoration. Outcome will be assessed at 1,3,6 months . |
| Intervention |
Human amniotic membrane with Biodentine |
Coronal Pulpotomy in mandibular molars using Human amniotic membrane with Biodentine as pulpotomy agents. Restoration with RMGIC and composite restoration. Outcome will be assessed at 1,3,6 months . |
|
|
Inclusion Criteria
|
| Age From |
13.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Clinical diagnosis of SIP without/with periapical rarefaction. (PAI score 1 to 3)
The tooth should give positive response to cold testing.
The tooth is restorable, probing pocket depth and mobility are within normal limits.
No signs of pulpal necrosis including sinus tract or swelling.
Mobility within normal limits.
Radiographically, no evidence of pathological root resorption, and periapical or furcal radiolucency.
|
|
| ExclusionCriteria |
| Details |
Teeth with immature roots
Non restorable teeth
Negative response to cold testing, the presence of sinus tract or swelling
No pulp exposure after caries excavation
Bleeding could not be controlled after full pulpotomy in 10 minutes
Insufficient bleeding after pulp exposure, the pulp is judged necrotic or partially necrotic
Systemic diseases like haemophilia, Von Willebrand disease, platelet abnormalities, and diabetes were excluded.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Patients will be asked to record their pain on a 100mm long visual analogue scale, with 0 representing no pain and 100 representing pain as bad as it could be.
An investigator blinded to the study group instructed all the participants.
|
24 and 48 hours
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Clinically, teeth will be evaluated for presence or absence of signs and symptoms associated with any pulpal or periapical disease (spontaneous or persistent pain, discomfort, tenderness on palpation or percussion, sinus, swelling of surrounding tissue), cold and electric pulp testing, periodontal status and the integrity of the restoration.
Radiographically, the assessment will be performed by two calibrated experienced endodontists independently for the evidence of any pathosis like periapical radiolucency (PAI upto 3), furcation involvement or internal/external root resorption. If any disagreement occurs, a consensus will be reached after a mutual discussion.
|
1, 3, 6 and 12 months |
|
|
Target Sample Size
|
Total Sample Size="36" Sample Size from India="36"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
15/07/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="15" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Patients will be evaluated for inclusion criteria in the study, 36 teeth meeting the inclusion criteria will be included. Patients will be informed of the details of the treatment, and informed consent will be obtained.
A clinical diagnosis consistent with Symptomatic Irreversible Pulpitis will be established in all cases based on a history of severe spontaneous lingering pain that could be reproduced by cold testing. After clinical and radiographic examination, the tooth will be anesthetized and, isolated using a dental dam. The cavity will be prepared using a sterile high-speed diamond bur under water coolant. The exposed pulpal tissue will be amputated up to the orifice. The pulpal blood sample will be collected in a test tube using a micro pipette. The bleeding will be controlled by placing a cotton pellet soaked with NaOCl over the pulpal wound for 2 minutes and repeated for a maximum of 10 minutes. Root canal therapy will be initiated in cases in which hemostasis cannot be achieved. Once hemostasis is confirmed, the tooth will randomly be allocated to 1 of 2 parallel arms using a predetermined computer-generated randomization. The patients will receive the allocated intervention Group 1 Biodentine or Group 2 Human amniotic membrane and Biodentine. The tooth will be sealed with light cured GIC and will be permanently restored with resin composite and a post operative periapical will be taken. The patients will have clinical and radiographic evaluation after 1, 3, 6 and 12 months. MMP9 values will be quantified in the pulpal blood sample collected during the pulpotomy with a fluorometric assay kit. |